Lead with the outcome
Begin with the business decision, scientific question, technical constraint or patient outcome—not a predetermined package of work.
Focused where needed.
Total by orientation.
Strategy, advisory and embedded operational leadership across the life-sciences value chain—combined with deep scientific, technical and operating expertise.
Our services trace a tailored path through FOURDTotal—FOURD’s proprietary approach for operationalizing Total Health—activating and connecting the capabilities most relevant to the challenge. We apply them selectively, where they sharpen decisions, connect disciplines and strengthen the path to patient outcomes.
FOURDynoBiology-to-outcomes architectureUnlock Nature. Strengthen Detection. Trace the path to Outcomes.
FOURDyadHybridization architectureConnect HealthTech with the relevant data, digital and AI capabilities.
FirstYOUHuman-value translationClient first in the engagement. Patient first in the outcome.
How we work
From counsel to capability.
Our engagement model flexes with the journey, scaling from targeted advisory support to embedded operational leadership as the work requires. At every stage, we connect the right capabilities and remain anchored to the decision, milestone or outcome that matters. By working alongside client teams, we turn immediate progress into enduring capability and sustained benefit realization.
Connect strategy to delivery
Translate direction into executable roadmaps, operating cadence, decisions and delivery support. Advice should survive contact with the work.
Embed at the right altitude
Move between leadership and the technical detail the situation requires, working alongside client teams rather than around them.
Build capability, not dependency
Leave stronger systems, clearer ownership, reusable tools and a team better equipped to continue after the engagement.
What Differentiates Us
Our Enduring Value
We embed with client teams to deliver outcomes and build lasting capability—so benefits are not realized just once, but sustained over time. We leave stronger organizations, not simply a deck of recommendations.
Services navigator
Where we work.
Expertise.Knowledge across the value chain and the connectors that run through it. Experience.Example shows how that work lands in three client contexts.
Expertise.Knowledge
Value chain · connecting servicesDifferent operating realities. One connected view.
Experience.Example
Case context 01Established biopharmaEnterprise scale
Case context 02Emerging biotechRunway aware
Case context 03Novel diagnostics & biotech platformsBiology forward
FOURD Services team
Senior expertise at the intersections.
Strategic Advisor & Operational Leader
Strategy · Portfolio · Enterprise execution
Biopharma executive and advisor with 25 years of experience across drug development, CMC/Technical Development, Technical Operations, portfolio strategy, and enterprise transformation. Brings deep technical expertise together with strategic breadth across the full biopharma value chain—from product and platform strategy through development, manufacturing, supply, quality, commercialization, and lifecycle management.
Strategic, Technical Advisor
CMC · MSAT · Process Sciences · Quality
Siddhartha (Sid) Jain is a biopharmaceutical leader with nearly two decades of experience in CMC development, MSAT, Process Sciences and Quality roles. Sid has contributed to the CMC development and manufacturing of several commercial biologics drugs (including Orencia, Eylea, Praluent and Dupixent) and clinical molecules (including one of the first AI-designed monoclonal antibodies).
Strategic, Technical Advisor
Technical Operations · CMC Strategy · Process Development · Manufacturing
Mani Sundararajan, Ph.D., is a biopharmaceutical executive with extensive experience in technical operations, CMC strategy, process development and drug development across the pharmaceutical and biotechnology industries. He has held senior leadership roles at organizations including Fulcrum Therapeutics, Seagen, Takeda, Shire, AstraZeneca, Bristol Myers Squibb and DuPont Pharmaceuticals, contributing to pharmaceutical development, manufacturing strategy and technical operations across complex development and supply networks.
Portrait forthcoming
Data, Digital & AI Lead
RWD/RWE · Digital measures · Governed AI
Shapes data architecture, digital operating models and governed AI applications that improve decisions and strengthen regulated workflows.
Portrait forthcoming
Clinical Development Lead
Clinical strategy · Trial execution · Evidence
Advises on clinical program strategy, trial design and execution, and evidence generation across biopharma and diagnostics portfolios.
Portrait forthcoming
Quality & Regulatory Lead
Quality systems · CMC regulatory · Compliance
Strengthens quality systems, remediation, and regulatory CMC pathways so programs stay inspection-ready across the product lifecycle.
Portrait forthcoming
Transformation & Operating Model Lead
Operating model · Change · Benefit realization
Designs operating models and transformation programs that embed lasting capability—so outcomes are delivered and sustained with client teams.
Ready to talk?